Background {#s1}
==========

Health inequalities exist between the most deprived and most affluent populations.[@R1] In particular, socioeconomic deprivation is associated with an increased risk of cardiovascular disease,[@R1] poor cognitive function,[@R2] postoperative mortality,[@R3] morbidity[@R4] and increased hospital stay[@R7] for both elective and emergency operations. The reasons for this are likely multifactorial, but poorly understood. In addition, it is now recognized that many patients admitted to emergency general services are managed non-operatively,[@R9] and it is not known whether all deprived patients, rather than only those who undergo an operation, are at a health disadvantage. Socioeconomic deprivation is not a hard barrier to healthcare access in the UK, as NHS healthcare is provided free at the point of care regardless of insurance status. However, deprivation may present a barrier to healthcare in other 'unseen' ways, which could lead to poorer outcomes.

Outcomes are also affected by comorbidities. Multiply comorbid patients undergoing emergency general surgery (EGS) procedures have an increased mortality risk,[@R10] which is exacerbated if the patient undergoes a high-risk EGS procedure.[@R8] Frailty is a predictor of perioperative complications, length of hospital stay,[@R11] mortality, institutional discharge and cost[@R12] in patients undergoing EGS. Although they are not synonymous, frailty and comorbidity are related in that frail patients are likely to be more comorbid.[@R12]

Although the impact of socioeconomic deprivation and comorbidity has been established, their combined impact is not known. We hypothesized that deprivation and comorbidity could have an additive or multiplicative effect on adverse outcomes. The aim of this study was to examine the impact of deprivation and comorbidity on mortality, discharge destination and length of hospital stay in patients undergoing EGS in Scotland.

Methods {#s2}
=======

This was a population-based retrospective cohort study.

Case definition and data sources {#s2-1}
--------------------------------

Data were obtained of all Scottish EGS admissions between 1997 and 2016 involving persons aged \>15 years. These data were sourced by querying the prospectively collected database held by the Information Services Division (ISD) of the Scottish Government,[@R13] to identify all patients within our study timeframe who were admitted as an emergency to a Scottish hospital under the care of a consultant (attending) general surgeon. Patients who are over 15 years of age in Scotland are admitted under adult general surgery services. The conditions treated by general surgeons in Scotland include undifferentiated abdominal pain, oesophago-gastric, hepatico-pancreatico-biliary, colorectal and acute breast conditions, and abdominal trauma. This includes conditions such as choledocholithiasis, diverticulitis and acute pancreatitis which may, in other countries, be managed by doctors other than surgeons. Surgeons in smaller hospitals may also treat patients with urological conditions, minor head injuries and thoracic trauma. ISD data are coded using the International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10). Anonymised data were hosted by the University of Aberdeen Data Safehaven in an Excel database (Microsoft Corporation, Redmond, Washington, USA).

The Scottish Index of Multiple Deprivation (SIMD) is a tool created by the Scottish Government which identifies small area concentrations of multiple deprivation in a consistent way. It identifies areas of poverty, inequality and decreased opportunity based on income, employment, education, health, access to services, crime and housing domains. It divides Scotland into 6976 data zones, each with a roughly equal population (approximately 760 residents per data zone).[@R14]

Extracted data for each EGS admission included patient age, sex, SIMD deciles (1=most deprived; 10=least deprived), 5-year Charlson Comorbidity Index (CCI),[@R15] whether patients had a surgical operation and outcome of the admission including mortality (inpatient, 30-day, 90-day and 1-year), discharge destination and length of hospital stay (LOS). CCI was described as no comorbidity (CCI 0), mild comorbidity (CCI 1 to 2), moderate comorbidity (CCI 3 to 4) and severe comorbidity (CCI \>4), in a similar fashion to several other publications.[@R16]

Analysis of data {#s2-2}
----------------

Binomial logistic regression was used to analyse discharge destination and inpatient, 30-day, 90-day and 1-year mortality. Poisson regression was used to analyse LOS. Statistical analysis was repeated for the subgroup of patients who underwent a surgical operation. All statistical analyses were conducted using SPSS (IBM Corporation, Armonk, New York, USA).

Ethical approval {#s2-3}
----------------

This project was registered with the research governance department of NHS Grampian and the University of Aberdeen, and approved by the Public Benefit and Privacy Panel (PBPP) of NHS Scotland (Ref 1617--0207).

Results {#s3}
=======

Demographics {#s3-1}
------------

A total of 1 477 810 EGS admissions meeting our inclusion criteria were identified ([figure 1](#F1){ref-type="fig"}); 237 824 (16.2%) were in SIMD decile 1 (most deprived) and 81 830 (5.6%) were in SIMD decile 10 (least deprived) ([table 1](#T1){ref-type="table"}). Of the total, 1 116 808 (75.6%) had no comorbidity (CCI 0), 299 657 (20.3%) had mild comorbidity (CCI 1 to 2), 37 558 (2.5%) had moderate comorbidity (CCI 3 to 4) and 23 787 (1.6%) had severe comorbidity (CCI \>4).

![Flow diagram of included and excluded cases. EGS, emergency general surgery.](tsaco-2020-000500f01){#F1}

###### 

Demographics of all patients admitted for EGS in Scotland 1997 to 2016

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  All patient demographics   All                 SIMD      CCI 5-Year                                                                                                                                     
  -------------------------- ------------------- --------- ------------ --------- --------- --------- --------- --------- --------- --------- --------- -------- --------- ----------- --------- -------- --------
  Age                        All adults (\>15)   All       1 468 238    237 824   195 889   176 224   162 909   149 591   136 094   123 954   108 515   95 408   81 830    1 116 808   299 657   37 558   23 787

                             Male                700 479   116 647      92 473    82 535    76 969    71 196    65 167    59 775    51 870    45 249    38 598   521 238   151 804     21 938    11 334   

                             Female              767 759   121 177      103 416   93 689    85 940    78 395    70 927    64 179    56 645    50 159    43 232   595 570   147 853     15 620    12 453   

                             16--30              All       276 349      51 865    40 337    33 603    29 994    26 530    23 065    21 129    18 756    16 032   15 038    266 649     10 571    767      667

                             Male                123 758   23 945       17 938    14 648    13 353    11 859    10 212    9573      8479      6973      6778     119 274   5214        347       314      

                             Female              152 591   27 920       22 399    18 955    16 641    14 671    12 853    11 556    10 277    9059      8260     147 375   5357        420       353      

                             31--45              All       308 175      59 724    45 061    37 280    32 749    29 232    25 604    23 477    21 735    18 593   14 720    277 158     28 330    3048     2219

                             Male                146 279   30 514       21 622    17 586    15 353    13 717    11 995    10 765    9852      8200      6675     131 640   13 604      1749      1038     

                             Female              161 896   29 210       23 439    19 694    17 396    15 515    13 609    12 712    11 883    10 393    8045     145 518   14 726      1299      1181     

                             46--60              All       312 074      51 976    41 866    37 046    33 846    30 910    28 541    26 708    23 566    20 682   16 933    238 620     61 717    7887     6034

                             Male                155 601   26 959       20 768    18 428    17 004    15 284    14 186    13 387    11 521    9961      8103     117 984   31 623      4657      2730     

                             Female              156 473   25 017       21 098    18 618    16 842    15 626    14 355    13 321    12 045    10 721    8830     120 636   30 094      3230      3304     

                             60--75              All       316 745      44 921    39 783    37 942    37 085    33 780    31 735    28 182    23 879    21 463   17 975    187 603     106 537   14 384   9853

                             Male                165 470   23 329       20 272    19 278    19 107    17 781    16 857    15 165    12 821    11 471    9389     93 903    58 654      8819      5021     

                             Female              151 275   21 592       19 511    18 664    17 978    15 999    14 878    13 017    11 058    9992      8586     93 700    47 883      5565      4832     

                             \>75                All       254 895      29 338    28 842    30 353    29 235    29 139    27 149    24 458    20 579    18 638   17 164    146 778     92 502    11 472   5014

                             Male                109 371   11 900       11 873    12 595    12 152    12 555    11 917    10 885    9197      8644      7653     58 437    42 709      6366      2231     

                             Female              109 371   17 438       16 969    17 758    17 083    16 584    15 232    13 573    11 382    9994      9511     88 341    49 793      5106      2783     

  LOS                        Total               Median    2            2         2         2         2         2         2         2         2         2        2         2           3         3        4

  25 Quartile                1                   1         1            1         1         1         1         1         1         1         1         1        1         1           1                  

  75 Quartile                4                   4         4            4         5         5         5         4         4         4         4         4        6         8           9                  

  D/C\                                           \%        79%          80%       79%       78%       78%       78%       78%       78%       78%       78%      79%       83%         66%       59%      58%
  Mortality                                                                                                                                                                                               

  Inpatient                  \%                  2%        2%           2%        2%        2%        2%        2%        2%        2%        2%        2%       1%        5%          6%        11%      

  30-day                     \%                  4%        3%           4%        4%        4%        4%        4%        4%        4%        4%        4%       2%        9%          13%       23%      

  90-day                     \%                  7%        7%           7%        8%        8%        8%        8%        8%        7%        7%        7%       3%        17%         23%       41%      

  1-year                     \%                  12%       12%          12%       13%       13%       13%       13%       13%       13%       13%       12%      8%        25%         32%       52%      
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CCI, Charlson Comorbidity Index; D/C, discharged home; LOS, length of hospital stay; n, number of admissions; SIMD, Scottish Index of Multiple Deprivation.

The subgroup of patients who underwent an operative procedure totalled 397 475 cases (26.9% of all admissions); 55 368 (14.0%) were in SIMD decile 1 and 26 043 (6.6%) in SIMD decile 10 ([table 2](#T2){ref-type="table"}). A total of 299 344 (75.3%) had no comorbidity, 82 146 (20.7%) had mild comorbidity, 9673 (2.4%) had moderate comorbidity and 6312 (1.6%) had severe comorbidity ([table 2](#T2){ref-type="table"}). Detailed breakdowns of admissions by diagnoses have been published in our previous works, including trends over the past 20 years.[@R9]

###### 

Demographics of patients admitted for EGS in Scotland who underwent an operative procedure 1997 to 2016

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Operative patient demographics   All                 SIMD      CCI 5-Year                                                                                                                        
  -------------------------------- ------------------- --------- ------------ -------- -------- -------- -------- -------- -------- -------- -------- -------- --------- --------- -------- ------ ------
  Age                              All adults (\>15)   All       395 234      55 368   49 924   47 274   44 052   40 949   37 547   34 271   31 420   28 386   26 043    299 344   82 146   9673   6312

                                   Male                196 185   27 893       24 373   23 167   21 496   20 283   18 499   17 374   15 718   14 229   13 153   146 621   42 312    5666     2931   

                                   Female              199 049   27 475       25 551   24 107   22 556   20 666   19 048   16 897   15 702   14 157   12 890   152 723   39 834    4007     3381   

                                   16--30              All       78 751       12 898   10 884   9410     8473     7614     6807     6308     5900     5279     5178      75 732    3298     194    135

                                   Male                39 697    6698         5426     4610     4262     3780     3350     3181     3025     2683     2682     38 167    1759      91       65     

                                   Female              39 054    6200         5458     4800     4211     3834     3457     3127     2875     2596     2496     37 565    1539      103      70     

                                   31--45              All       82 907       13 715   11 476   10 079   8964     8036     7204     6543     6306     5734     4850      74 677    7533     780    486

                                   Male                41 612    7087         5658     4954     4454     4146     3597     3294     3123     2818     2481     37 457    3857      458      221    

                                   Female              41 295    6628         5818     5125     4510     3890     3607     3249     3183     2916     2369     37 220    3676      322      265    

                                   46--60              All       82 405       11 641   10 281   9791     8847     8265     7879     7398     6747     6069     5487      62 268    16 913   2090   1622

                                   Male                42 352    6095         5194     5119     4522     4181     3959     3913     3445     3091     2833     31 483    9145      1273     746    

                                   Female              40 053    5546         5087     4672     4325     4084     3920     3485     3302     2978     2654     30 785    7768      817      876    

                                   60--75              All       86 349       10 616   10 286   10 285   10 164   9529     8799     7939     6934     6274     5523      50 063    30 104   3776   2771

                                   Male                44 967    5424         5194     5226     5194     5013     4645     4251     3702     3378     2940     24 906    16 545    2346     1368   

                                   Female              41 382    5192         5092     5059     4970     4516     4154     3688     3232     2896     2583     25 157    13 559    1430     1403   

                                   \>75                All       64 822       6498     6997     7709     7604     7505     6858     6083     5533     5030     5005      36 604    24 298   2833   1298

                                   Male                27 557    2589         2901     3258     3064     3163     2948     2735     2423     2259     2217     14 608    11 006    1498     531    

                                   Female              37 265    3909         4096     4451     4540     4342     3910     3348     3110     2771     2788     21 996    13 292    1335     767    

  LOS                              Total               Median    3            3        3        3        3        3        3        3        3        3        3         3         4        4      6

  25 Quartile                      1                   1         1            1        1        1        1        1        1        1        1        1        2         2         2               

  75 Quartile                      6                   6         6            6        6        6        6        6        6        6        6        5        9         9         14              

  D/C\                                                 \%        81%          82%      81%      80%      80%      80%      80%      80%      80%      80%      81%       86%       66%      58%    61%
  Mortality                                                                                                                                                                                        

  Inpatient                        \%                  1%        1%           1%       1%       1%       1%       1%       1%       1%       1%       1%       0%        3%        5%       10%    

  30 day                           \%                  3%        3%           3%       4%       3%       3%       3%       3%       3%       3%       3%       1%        8%        12%      20%    

  90 day                           \%                  7%        7%           7%       7%       7%       7%       7%       7%       6%       7%       6%       3%        16%       22%      41%    

  1 year                           \%                  13%       11%          11%      12%      12%      12%      12%      12%      11%      11%      11%      7%        23%       32%      52%    
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CCI, Charlson Comorbidity Index; D/C, discharged home; LOS, length of hospital stay; n, number of admissions; SIMD, Scottish Index of Multiple Deprivation.

Outcomes {#s3-2}
--------

A total of 1 452 341 (98.3%) patients were discharged from hospital and 25 469 (1.7%) died in hospital ([table 1](#T1){ref-type="table"}); 1 160 917 patients (78.6%) were discharged home, while 291 424 (19.7%) were discharged from the acute care setting to a non-home environment ([table 1](#T1){ref-type="table"}). The overall 30-day, 90-day and 1-year crude mortality rates were 3.7%, 7.2% and 12.4%, respectively ([table 1](#T1){ref-type="table"}). These figures remained unchanged depending on SIMD decile, but were greatly affected by comorbidity.

Among the operative subgroup, 319 970 (80.5%) of patients were discharged directly home and 77 505 (19.5%) were not ([table 2](#T2){ref-type="table"}). A total of 392 366 (98.7%) were discharged from hospital and 5109 (1.29%) died in hospital ([table 2](#T2){ref-type="table"}). Overall 30-day, 90-day and 1-year crude mortality rates were 3.2%, 6.7% and 11.4%, respectively ([table 2](#T2){ref-type="table"}). As with the overall cohort of admissions, the outcomes of operative patients were largely affected by CCI but not by SIMD ([table 2](#T2){ref-type="table"}).

Combined analysis {#s3-3}
-----------------

This finding is corroborated by [online supplementary table 1](#SP1){ref-type="supplementary-material"}, which shows that crude mortality and mortality risk ratios are not affected by deprivation, but are greatly affected as comorbidity increases. When the referent is set to no comorbidity (CCI 0) and the least deprivation level (SIMD 10), admissions with CCI \>4 had an inpatient mortality risk 16 to 23 times and 1-year mortality risk 90 to 96 times that of the comparison group ([online supplementary table 1](#SP1){ref-type="supplementary-material"}). Similarly, for the subgroup of admissions which included a surgical operation, admissions with CCI \>4 had an inpatient mortality risk 24 to 41 times ([online supplementary table 2](#SP2){ref-type="supplementary-material"}) and 1-year mortality risk 156 to 173 times that of the referent group ([online supplementary table 2](#SP2){ref-type="supplementary-material"}).
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Statistical analysis {#s3-4}
--------------------

Logistic regression analyses showed that, compared with those with CCI 0, admissions with CCI \>4 were less likely to be discharged home (OR 0.376, 95% CI 0.367 to 0.387) and had higher inpatient mortality (OR 13.741, 95% CI 13.094 to 14.42), 30-day mortality (OR 14.085, 95% CI 13.594 to 14.594), 90-day mortality (OR 14.679, 95% CI 14.258 to 15.112) and 1-year mortality (OR 9.849, 95% CI 9.586 to 10.12) ([table 3](#T3){ref-type="table"}).

###### 

Logistic regression analyses for discharge home and inpatient, 30-day, 90-day and 1-year mortality

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Logistic regression analysis   Parameter   Age    Male   SIMD 1   SIMD 2   SIMD 3   SIMD 4   SIMD 5   SIMD 6   SIMD 7   SIMD 8   SIMD 9   CCI 1 to 2   CCI 3 to 4   CCI \>4
  ------------------------------ ----------- ------ ------ -------- -------- -------- -------- -------- -------- -------- -------- -------- ------------ ------------ ---------
  All patients                                                                                                                                                        

  Discharge\                     OR          0.98   0.95   0.97     0.97     0.95     0.96     0.95     0.98     0.98     0.97     0.97     0.57         0.43         0.38
  home                                                                                                                                                                

  Lower 95% CI                   0.98        0.94   0.95   0.95     0.93     0.94     0.93     0.95     0.96     0.95     0.95     0.57     0.42         0.37         

  Upper 95% CI                   0.98        0.96   0.99   0.99     0.97     0.98     0.97     1.00     1.01     0.99     0.99     0.58     0.44         0.39         

  Inpatient mortality            OR          1.07   0.95   1.36     1.41     1.30     1.24     1.16     1.13     1.16     1.15     1.09     3.95         5.56         13.74

  Lower 95% CI                   1.07        0.92   1.28   1.32     1.21     1.16     1.08     1.05     1.08     1.07     1.01     3.83     5.29         13.09        

  Upper 95% CI                   1.07        0.97   1.46   1.50     1.39     1.33     1.24     1.21     1.24     1.24     1.18     4.07     5.84         14.42        

  30-day mortality               OR          1.06   1.07   1.28     1.27     1.24     1.15     1.14     1.10     1.11     1.11     1.05     3.79         5.54         14.09

  Lower 95% CI                   1.06        1.05   1.22   1.21     1.18     1.10     1.09     1.05     1.06     1.05     1.00     3.72     5.35         13.59        

  Upper 95% CI                   1.06        1.09   1.34   1.33     1.30     1.21     1.20     1.16     1.17     1.16     1.11     3.87     5.73         14.59        

  90-day mortality               OR          1.05   1.05   1.19     1.20     1.17     1.11     1.09     1.08     1.09     1.08     1.08     3.48         5.09         14.68

  Lower 95% CI                   1.05        1.04   1.15   1.16     1.13     1.08     1.05     1.04     1.05     1.04     1.04     3.43     4.95         14.26        

  Upper 95% CI                   1.05        1.06   1.23   1.24     1.21     1.15     1.13     1.12     1.13     1.12     1.12     3.54     5.23         15.11        

  1-year mortality               OR          1.03   1.00   1.11     1.11     1.09     1.06     1.04     1.04     1.03     1.04     1.07     2.61         3.78         9.85

  Lower 95% CI                   1.03        0.99   1.08   1.08     1.06     1.03     1.01     1.01     1.01     1.01     1.04     2.58     3.70         9.59         

  Upper 95% CI                   1.03        1.01   1.14   1.14     1.12     1.08     1.07     1.07     1.06     1.07     1.10     2.64     3.87         10.12        

  Operative patients                                                                                                                                                  

  Discharge\                     OR          0.97   1.00   0.92     0.96     0.95     0.96     0.95     0.99     0.97     0.96     0.95     0.49         0.36         0.37
  home                                                                                                                                                                

  Lower 95% CI                   0.97        0.98   0.89   0.92     0.91     0.93     0.91     0.95     0.93     0.92     0.91     0.48     0.34         0.35         

  Upper 95% CI                   0.97        1.02   0.96   1.00     0.99     1.00     0.99     1.03     1.01     1.00     1.00     0.50     0.37         0.39         

  Inpatient mortality            OR          1.07   0.97   1.62     1.55     1.41     1.36     1.30     1.08     1.27     1.16     1.13     3.85         5.60         15.21

  Lower 95% CI                   1.06        0.92   1.41   1.34     1.22     1.17     1.12     0.92     1.09     0.99     0.96     3.60     5.01         13.75        

  Upper 95% CI                   1.07        1.03   1.87   1.79     1.63     1.57     1.50     1.26     1.48     1.36     1.33     4.12     6.25         16.82        

  30-day mortality               OR          1.06   1.09   1.53     1.40     1.38     1.21     1.18     1.13     1.18     1.11     1.11     3.37         5.26         12.16

  Lower 95% CI                   1.06        1.05   1.39   1.28     1.25     1.10     1.07     1.02     1.07     1.00     1.00     3.24     4.90         11.31        

  Upper 95% CI                   1.06        1.13   1.68   1.54     1.51     1.33     1.30     1.25     1.31     1.23     1.24     3.52     5.65         13.06        

  90-day mortality               OR          1.05   1.07   1.33     1.28     1.26     1.14     1.14     1.11     1.12     1.08     1.10     3.51         5.28         15.46

  Lower 95% CI                   1.05        1.04   1.25   1.20     1.18     1.06     1.06     1.04     1.05     1.00     1.02     3.41     5.00         14.61        

  Upper 95% CI                   1.05        1.10   1.42   1.37     1.34     1.21     1.22     1.19     1.20     1.16     1.19     3.61     5.57         16.35        

  1-year mortality               OR          1.03   1.06   1.22     1.18     1.14     1.09     1.09     1.09     1.08     1.06     1.09     2.82         4.25         11.21

  Lower 95% CI                   1.03        1.04   1.16   1.12     1.08     1.03     1.03     1.03     1.02     1.00     1.03     2.76     4.05         10.64        

  Upper 95% CI                   1.03        1.08   1.28   1.24     1.20     1.15     1.14     1.15     1.14     1.12     1.15     2.89     4.45         11.82        
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

SIMD, Scottish Index of Multiple Deprivation; CCI, Charlson Comorbidity Index.

Compared with the most affluent population (SIMD 10), the most deprived population (SIMD 1) were less likely to be discharged home (OR 0.974, 95% CI 0.954 to 0.994) and had higher inpatient mortality (OR 1.363, 95% CI 1.276 to 1.456), 30-day mortality (OR 1.278, 95% CI 1.221 to 1.338), 90-day mortality (OR 1.192, 95% CI 1.152 to 1.233) and 1-year mortality (OR 1.113, 95% CI 1.084 to 1.142) ([table 3](#T3){ref-type="table"}). Similar results are seen among those who had an operation ([table 3](#T3){ref-type="table"}).

Poisson analysis showed that, compared with those with CCI 0, admissions with CCI \>4 had longer LOS (OR 1.685, 95% CI 1.677 to 1.694), and compared with the most affluent population (SIMD 10), the most deprived population (SIMD 1) also had a longer LOS (OR 1.11, 95% CI 1.11 to 1.12) ([table 4](#T4){ref-type="table"}). A similar effect occurred among admissions of patients who had an operation ([table 4](#T4){ref-type="table"}).

###### 

Poisson regression analyses for length of hospital stay

  Poisson analysis     Parameter   Male   SIMD 1   SIMD 2   SIMD 3   SIMD 4   SIMD 5   SIMD 6   SIMD 7   SIMD 8   SIMD 9   Age    CCI 1 to 2   CCI 3 to 4   CCI \>4
  -------------------- ----------- ------ -------- -------- -------- -------- -------- -------- -------- -------- -------- ------ ------------ ------------ ---------
  All patients         OR          0.87   1.11     1.10     1.10     1.10     1.08     1.08     1.07     1.06     1.03     1.02   1.35         1.51         1.69
  Lower 95% CI         0.87        1.11   1.09     1.10     1.09     1.08     1.07     1.06     1.05     1.02     1.02     1.35   1.51         1.68         
  Upper 95% CI         0.87        1.12   1.10     1.10     1.10     1.09     1.08     1.07     1.06     1.03     1.02     1.36   1.52         1.69         
  Operative patients   OR          0.85   1.13     1.08     1.08     1.06     1.06     1.07     1.06     1.03     1.03     1.02   1.32         1.35         1.71
  Lower 95% CI         0.85        1.12   1.08     1.07     1.05     1.05     1.06     1.06     1.02     1.02     1.02     1.31   1.34         1.70         
  Upper 95% CI         0.86        1.14   1.09     1.09     1.07     1.06     1.07     1.07     1.03     1.04     1.02     1.32   1.36         1.73         

Reference variables: Female; SIMD 10; CCI 0.

CCI, Charlson Comorbidity Index; SIMD, Scottish Index of Multiple Deprivation.

Discussion {#s4}
==========

This study has demonstrated, using population-level data, that increased levels of comorbidity and, to a lesser extent, socioeconomic deprivation significantly affect outcomes of EGS admissions in a free at the point of care healthcare system. Not only is this a novel finding, it is methodologically unique from a public health perspective in that we examined the whole population of EGS admissions over 20 years instead of examining the impact on a specific diagnosis or operation over a shorter time period.

These findings have implications for public health policy and service delivery planning. Patients with multimorbidity are at increased risk of in-hospital, short-term and medium-term mortality.[@R19] They are also at higher risk of discharge to a non-home environment. Early identification of those individuals who are likely to require further care needs may need to be explored in order to ensure patient movement through the acute sectors of NHS care. Our data also show that the need for further support structures is greatest in the deprived regions.

There are also clinical applications from this work: clinicians need to better appreciate (and quantify) the impact that comorbidity and, to a lesser extent, socioeconomic deprivation have on LOS, discharge destination and both in-hospital and post-discharge mortality. This pertains to the very nature of patient--provider discussion in setting the expectations for length of hospital admissions, the likelihood of being discharged home directly or the likelihood of inpatient or post-discharge death, regardless of operative intervention. While it is not possible to suggest a \'comorbidity threshold\' for involving services such as physiotherapy, occupational therapy, social work or geriatrics, clinicians should be aware that, compared with patients with no comorbidity, patients with minor comorbidity (CCI 1 to 2) are half as likely to be discharged home (all patients OR 0.57, operative patients OR 0.49), and patients with major comorbidity (CCI \>4) are only one-third as likely to be discharged home (all patients OR 0.38, operative patients OR 0.37) ([table 3](#T3){ref-type="table"}). Interestingly, the number of patients who are discharged home is the same in both the operative and non-operative groups. This finding suggests that the barriers to discharge are not related to treatment.

Other studies have shown associations between socioeconomic deprivation and health outcomes. The Whitehall studies of British civil servants identified increased morbidity and cardiovascular risk among those working in lower employment grades, and this effect was observed to be sustained for over a decade.[@R1] Packard *et al* showed that socioeconomic adversity in children negatively affects their health and cognition in adult life.[@R2] Overall mortality was higher in the deprived population compared with the affluent population (HR 1.36, 95% CI 1.09 to 1.69) for patients who underwent resection for colorectal cancer in Scotland between 1991 and 1994.[@R3] Deprivation was associated with increased major and minor complications following ileostomy reversal in a Scottish population.[@R4] Socioeconomic deprivation was independently associated with higher mortality rates after kidney transplantation, with the least deprived having reduced 5-year mortality (HR 0.65, 95% CI 0.54 to 0.77).[@R5] Taylor *et al* showed that, in patients undergoing coronary artery bypass graft, deprivation was independently associated with increased risk of postoperative myocardial infarction, stroke, death and prolonged hospital stay.[@R6] Wrigley *et al* showed that socioeconomic deprivation was adversely associated with survival in patients with colorectal cancer,[@R7] with HR for mortality from colorectal cancer in the most deprived areas of 1.12 (95% CI 1.00 to 1.25) and all-cause mortality 1.18 (95% CI 1.07 to 1.30). Symons *et al* showed that high-risk EGS patients with Carstairs score 5 (most deprived) compared with Carstairs score 1 (least deprived) had a higher 30-day mortality risk with OR 1.22 (95% CI 1.18 to 1.27).[@R8]

The relatively small effect of deprivation on outcomes may be explained by Scotland's single-payer healthcare system. Healthcare is delivered free at the point of care, including primary care (general practitioners) and secondary/tertiary care (hospital specialists), both in the elective and emergency setting. This may reduce some financial barriers to receiving healthcare, thereby increasing access for those who in other healthcare systems may struggle to receive emergency medical care.

There is evidence in the literature that comorbidities affect the outcome of patients undergoing EGS, but most focus on patients who have had operative procedures. Patients undergoing EGS procedures who had a higher CCI had increased 30-day mortality postoperatively (adjusted OR 1.39, 95% CI 1.11 to 1.73).[@R10] Another study showed that this effect was even greater for patients undergoing high-risk EGS procedures, as those patients with CCI \>2 had a higher 30-day mortality (OR 2.61, 95% CI 2.56 to 2.67).[@R8] Many studies have focused on elderly EGS patients, and concluded that frailty was a significant predictor of outcomes including perioperative complications, length of hospital stay,[@R11] mortality, institutional discharge and cost.[@R12] Frailty and comorbidity are related, in that frail patients have a higher CCI score,[@R12] but they are not synonymous. Recent efforts have focused on these factors; in particular, the National Emergency Laparotomy Audit (NELA) identified that nearly half of all emergency laparotomies are performed on patients over 70, that their mortality rate, LOS, comorbidity and frailty are much higher than younger patients, and that only 3% of hospitals provide regular proactive assessments from geriatricians.[@R20] Similarly, in Scotland, 49% of emergency laparotomies were performed in patients aged \>65 years and 16% of these were frail, scoring \>4 in the Rockwood Clinical Frailty Score,[@R23] and it has been suggested that we build \'clinical relationships with geriatricians to develop targeted frailty pathways\'. The UK-wide Emergency Laporatomy and Frailty study reported that, of patients aged \>65 years undergoing laparotomy, 20% are frail, which is associated with increased postoperative mortality, morbidity, length of critical care stay and LOS.[@R24]

The information collected at routine assessment at time of admission (the 'clerking in' of patients) could be better used to inform the likely hospital course. An area of future research could be to develop a prediction score at admission based on factors which predict likelihood of various outcomes, such as LOS, discharge destination and mortality. This has been done for perioperative mortality (P-POSSUM)[@R25] and could have clinical relevance---for example, to trigger patients' needs assessments (physiotherapy, occupational therapy, social care requirements), review by a geriatrician, or early discussions/decisions about ceilings of care with the patient and their families.

We defined EGS as those patients who were admitted to a Scottish hospital under the care of a consultant (attending) general surgeon.[@R9] There have been other methods of defining EGS,[@R27] however this is the most pragmatic definition in the context of the UK as it defines the actual service delivered instead of only including the patients whose coded diagnosis at discharge falls within the remit of the general surgical specialism ('ideal' definition). This is an important distinction for two reasons: (1) because the nature of EGS service is such that diagnoses are often dependent on laboratory and radiological services, which may take time, and thus many admissions result in diagnoses which would not normally be looked after by general surgeons; and (2) clinical resources should be allocated based on actual demand, not ideal situations.

This study has strengths and limitations. Its greatest strength is the large number of hospital episodes included. The population-wide data have great advantages in that there are very few missing data, but there is also a lack of granularity. This limited the variables which could be controlled for, and thus limited interpretations of findings. For example, there is no information on the specific comorbidities which contribute to make up the CCI, so for any individual admission we do not know whether the outcome was influenced by specific comorbidities (cardiac, respiratory, immunological, extremes of body mass index, frailty) or other factors including presenting physiology, case severity, or clinical and radiological findings. Therefore, although there is little bias introduced in the dataset and the confidence intervals are narrow given the very large sample size, detailed associations related to underlying conditions could not be determined. There is also a risk of confounding factors which could not be controlled for, given the limited breadth of the dataset. Another limitation is that SIMD describes deprivation within post code regions, therefore not all individuals within a particular data zone will have the same characteristics. Data providers quality assure data for all indicators before providing them to the Office of the Chief Statistician and Performance, which then performs further checks on indicators and domains.[@R14] Data are correlated with previous years, investigated and considered for amendment if they have changed dramatically.[@R14] Therefore, despite not being tailored for the individual, SIMD is likely the most reliable method of characterising deprivation in Scotland. As a multicenter study, it would have been pertinent to study clustering effects by facility, but we did not have a facility variable or field in the database so it could not be performed. Further work on a representative sample of these patients using more detailed data could provide prognostic information at the point of admission, augmenting the prognostic work resulting in the NELA score and P-POSSUM score for emergency laparotomy.[@R22]

The generalizability of these results may be wide. Although the data came from a single nation (Scotland), it was a population-wide sample over the course of 20 years, with very few missing data, and therefore may compare to similar populations (highly developed Western nations). Lastly, because we included data from the last 20 years, if there had been a change in the direction of any effect over time the conclusions generated may be misleading.

In conclusion, increased levels of comorbidity and, to a lesser extent, socioeconomic deprivation significantly adversely affects EGS outcomes including mortality, discharge destination and length of hospital stay. Further work is warranted to determine whether prognostic scoring at EGS admission could be developed, which can help guide treatment pathways for patients.
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